((1-Chloro-2-methylpropan-2-yl)oxy)trimethylsilane
((1-Chloro-2-methylpropan-2-yl)oxy)trimethylsilane is an intermediate for the synthesis of 3-Hydroxy Bortezomib (H818150), which is a metabolite of Bortezomib (B675700); the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer.
Supplier | BOC Sciences |
---|---|
Product # | BB069173 |
Pricing | Inquire |
Cas | 31557-15-0 |
Molecular Weight | 180.75 |
Molecular Formula | C7H17ClOSi |